Pulse Biosciences, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Pulse Biosciences, Inc. (PLSE) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$42.57 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-03.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-03
- Pulse Biosciences, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$42.57M, a 684.63% decline year-over-year.
- Pulse Biosciences, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $44.77M.
- Pulse Biosciences, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$463.00K, a 101.52% decline year-over-year.
- Pulse Biosciences, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$3.87M.
- Pulse Biosciences, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $47.72M, a 3579.03% increase from fiscal 2017.
- Pulse Biosciences, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $1.30M.
- Pulse Biosciences, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$1.52M.
- Pulse Biosciences, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$3.40M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 7 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2019-03-31 | -$42.57M 10-Q · filed 2019-05-03 | $2.21M derived: sum of 2 quarters · filed 2019-05-03 | $1.74M derived: sum of 3 quarters · filed 2019-05-03 | -$2.13M derived: sum of 4 quarters · filed 2019-05-03 | |
| 2018-12-31 | $44.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $44.31M derived: sum of 2 quarters · filed 2019-03-14 | $40.44M derived: sum of 3 quarters · filed 2019-03-14 | $47.72M 10-K · filed 2019-03-14 | |
| 2018-09-30 | -$463.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$4.34M derived: sum of 2 quarters · filed 2018-11-01 | $2.94M 10-Q · filed 2018-11-01 | -$26.09M derived: sum of 4 quarters · filed 2019-05-03 | |
| 2018-06-30 | -$3.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $3.41M 10-Q · filed 2018-07-31 | -$25.63M derived: sum of 3 quarters · filed 2019-05-03 | $4.80M derived: sum of 4 quarters · filed 2019-05-03 | |
| 2018-03-31 | $7.28M 10-Q · filed 2019-05-03 | -$21.76M derived: sum of 2 quarters · filed 2019-05-03 | $8.68M derived: sum of 3 quarters · filed 2019-05-03 | $7.92M derived: sum of 4 quarters · filed 2019-05-03 | |
| 2017-12-31 | -$29.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $1.40M derived: sum of 2 quarters · filed 2019-03-14 | $635.00K derived: sum of 3 quarters · filed 2019-03-14 | $1.30M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $30.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $29.67M derived: sum of 2 quarters · filed 2018-11-01 | $30.33M 10-Q · filed 2018-11-01 | $27.80M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | -$761.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$99.00K 10-Q · filed 2018-07-31 | -$2.64M derived: sum of 3 quarters · filed 2019-03-14 | -$18.22M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-03-31 | $662.00K 10-Q · filed 2018-05-08 | -$1.88M derived: sum of 2 quarters · filed 2019-03-14 | -$17.46M derived: sum of 3 quarters · filed 2019-03-14 | $646.00K derived: sum of 4 quarters · filed 2019-03-14 | |
| 2016-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$18.13M derived: sum of 2 quarters · filed 2019-03-14 | -$16.00K derived: sum of 3 quarters · filed 2019-03-14 | -$1.52M 10-K · filed 2019-03-14 | |
| 2016-09-30 | -$15.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $2.52M derived: sum of 2 quarters · filed 2017-11-08 | $1.02M 10-Q · filed 2017-11-08 | -$321.00K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $18.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $16.61M 10-Q · filed 2017-08-10 | $15.27M derived: sum of 3 quarters · filed 2018-03-16 | $14.28M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | -$1.50M 10-Q · filed 2017-05-10 | -$2.84M derived: sum of 2 quarters · filed 2018-03-16 | -$3.83M derived: sum of 3 quarters · filed 2018-03-16 | -$4.45M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$2.33M derived: sum of 2 quarters · filed 2018-03-16 | -$2.95M derived: sum of 3 quarters · filed 2018-03-16 | -$3.40M 10-K · filed 2018-03-16 | |
| 2015-09-30 | -$987.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.60M derived: sum of 2 quarters · filed 2016-11-14 | -$2.06M 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | -$616.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$1.07M 10-Q · filed 2016-08-10 | |||
| 2015-03-31 | -$457.00K 10-Q · filed 2016-06-27 | ||||
| 2014-12-31 | $7.01M 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |